Effects of iodotyrosines, thyronines, iodothyroacetic acids and thyromimetic analogues on in vitro copper-induced oxidation of low-density lipoproteins

Biochemical Pharmacology

Volumn 55, Issue 10, 1998, Pages 1591-1601

  Chomard, Philippe ^a,c   Seguin, Carole ^b   Loireau, Annie ^b   Autissier, Nicole ^b   Artur, Yves ^a  

^a U de Biochimie Pharmacologique   (France)

^b UFR Sci Pharmaceutiques B   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Antioxidant; Copper oxidation; In vitro; Iodothyronines; Low density lipoprotein; Thyromimetics

Indexed keywords

COPPER; IODOTYROSINE; LOW DENSITY LIPOPROTEIN; THYROID HORMONE DERIVATIVE; THYRONINE; THYRONINE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL REACTION KINETICS; CHOLESTEROL BLOOD LEVEL; HORMONE ACTION; HUMAN; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ACETIC ACIDS; CHOLESTEROL; COPPER; HUMANS; LIPOPROTEINS, LDL; MOLECULAR MIMICRY; MONOIODOTYROSINE; OXIDATION-REDUCTION; THYRONINES; TRIGLYCERIDES;

EID: 0032524962     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00675-8     Document Type: Article

References (34)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity . N Engl J Med. 320:1989;915-924.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
3. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage implications for cholesterol deposition in atherosclerosis . Ann Rev Biochem. 52:1983;483-488.
4. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 43:1992;219-225.
5. Hensrud DD, Heimburger DC. Antioxidant status, fatty acids and cardiovascular disease. Nutrition. 10:1994;170-175.
6. Dobrian A, Mora R, Simionescu M, Simionescu N. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins antioxidant effect of albumin . Biochim Biophys Acta. 1169:1993;12-24.
7. Gieseg S, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett. 343:1994;188-194.
8. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med. 13:1992;341-390.
9. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med. 23:1991;573-581.
10. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis a clinical biochemistry perspective . Clin Chem. 42:1996;498-506.
11. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc. 68:1993;860-866.
12. Franklin JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol. 38:1993;453-459.
13. Kung AWC, Pang RWC, Lauder I, Lam KSL, Janus ED. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem. 41:1995;226-231.
14. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Intern Med. 150:1990;2097-2100.
15. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol. 37:1992;411-414.
16. Benvenga S, Robins J. Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL an additional mode of entry of thyroxine into cells . Endocrinology. 126:1990;933-941.
17. Hanna AN, Feller DR, Witiak DT, Newman HAI. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochem Phamacol. 45:1993;753-762.
18. Hanna AN, Titterington LC, Lantry LE, Stephens RE, Newman HAI. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Biochem Pharmacol. 50:1995;1627-1633.
19. Kleinweld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation application of a short procedure for isolating low-density lipoprotein . Clin Chem. 38:1992;2066-2072.
20. Markwell MAK, Haas SM, Buber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87:1978;206-210.
21. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm. 6:1989;67-75.
22. Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H. Factors affecting resistance of low density lipoproteins to oxidation. Lipids. 31:1996;S71-S76.
23. Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K, Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim Biophys Acta. 1123:1992;334-341.
24. Nair V, Cooper CS, Vietti DE, Turner GA. The chemistry of lipid peroxidation metabolites crosslinking reactions of malondialdehyde . Lipids. 21:1986;6-10.
25. Nardini M, D'Aquino M, Tomassi G, Gentili V, Difelice M, Scaccini C. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Rad Biol Med. 19:1995;541-552.
26. Collange E and Pâris M, Physicochimie des hormones thyroïdiennes I. Etude potentiométrique de l'ionisation et de la complexation par le cuivre (II) de la thyroxine et de ses analogues dans le solvant mixte diméthylsulfoxyde 80%-eau 20%. Bull Soc Chim Fr n° 1-2:I44-I48, 1983.
27. Benvenga S, Cahnmann HJ, Robbins J. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Endocrinology. 127:1990;2241-2246.
28. Jorgensen EC. Thyroid hormones and analogs. II. Structure-activity relalionships. Li CH. Hormonal Proteins and Peptides, vol. VI, Thyroid Hormones. 1978;107-204 Academic Press, New York.
29. Laranjinha JAN, Almeida LM, Madeira VMC. Reactivity of dietary phenolic acids with peroxyl radicals antioxidant activity upon low density lipoprotein peroxidation . Biochem Pharmacol. 48:1994;487-494.
30. 2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem Pharmacol. 51:1996;395-402.
31. Jorgensen EC. Thyroid hormones and analogs. I. Synthesis, physical properties and theoretical calculations. Li CH. Hormonal Proteins and Peptides, vol VI, Thyroid Hormones. 1978;57-105 Academic Press, New York.
32. Hodin R, Lazar M, Wintman B. Identification of a thyroid hormone receptor that is pituitary-specific. Science. 244:1989;76-79.
33. Leeson PD, Ellis D, Emmett JC, Shah VP, Showell GA, Underwood AH. Thyroid hormone analogues. Synthesis of 3′-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart. J Med Chem. 31:1988;37-54.
34. Smith C, Mitchinson MJ, Aruoma MJ, Halliwell OI. Stimulation of lipid peroxidation and hydroxyl radical generation by the content of human atherosclerosis lesions. Biochem J. 286:1992;901-905.